Joanna Mika Selected Research

Inflammation (Inflammations)

1/2021	Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
1/2018	Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Mika Research Topics

Disease

83	Neuralgia (Stump Neuralgia) 11/2023 - 05/2004
47	Pain (Aches) 03/2024 - 05/2004
26	Hypersensitivity (Allergy) 07/2023 - 01/2007
16	Hyperalgesia 06/2017 - 06/2004
7	Diabetic Neuropathies (Diabetic Neuropathy) 10/2020 - 01/2013
5	Chronic Pain 10/2021 - 08/2011
4	Chronic Disease (Chronic Diseases) 07/2023 - 01/2018
4	Wounds and Injuries (Trauma) 12/2020 - 01/2018
4	Neuroinflammatory Diseases 01/2020 - 01/2015
3	Peripheral Nervous System Diseases (PNS Diseases) 05/2023 - 03/2019
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2020 - 01/2020
2	Neoplasms (Cancer) 12/2022 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Brain Injuries (Brain Injury) 12/2020 - 01/2020
2	Cancer Pain 01/2018 - 01/2013
2	Acute Pain 10/2017 - 12/2013
2	Headache (Headaches) 03/2017 - 01/2013
2	Body Weight (Weight, Body) 10/2016 - 09/2013
2	Immunoglobulin G4-Related Disease 06/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

45	Opioid Analgesics (Opioids)IBA 03/2024 - 05/2008
43	Analgesics (Analgesic Drugs)IBA 11/2023 - 05/2004
36	Morphine (MS Contin)FDA LinkGeneric 05/2023 - 05/2004
21	LigandsIBA 12/2022 - 09/2008
18	Minocycline (Cyclops)FDA LinkGeneric 01/2018 - 04/2007
16	ChemokinesIBA 07/2023 - 01/2015
13	Messenger RNA (mRNA)IBA 12/2020 - 06/2004
12	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 10/2015
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2005
8	Neutralizing AntibodiesIBA 07/2023 - 01/2018
7	CytokinesIBA 01/2021 - 06/2004
7	InterleukinsIBA 01/2020 - 05/2008
6	Streptozocin (Streptozotocin)FDA Link 10/2020 - 01/2013
6	Pentoxifylline (Trental)FDA LinkGeneric 09/2013 - 06/2004
5	NociceptinIBA 06/2017 - 05/2004
5	Antidepressive Agents (Antidepressants)IBA 10/2016 - 01/2013
4	UCB 35625IBA 07/2023 - 01/2018
4	Maraviroc FDA Link 07/2023 - 01/2016
4	KynurenineIBA 01/2023 - 03/2016
4	Opioid Receptors (Opioid Receptor)IBA 09/2021 - 05/2004
4	Doxepin (Mareen)FDA LinkGeneric 03/2021 - 01/2013
4	Type A Botulinum Toxins (Botox)FDA Link 03/2021 - 11/2016
4	Complement System Proteins (Complement)IBA 12/2020 - 05/2008
4	incobotulinumtoxinA FDA Link 01/2018 - 11/2016
3	Chemokine ReceptorsIBA 07/2023 - 12/2020
3	mirogabalinIBA 07/2023 - 01/2021
3	CC ChemokinesIBA 10/2020 - 11/2017
3	Dynorphins (Dynorphin)IBA 04/2020 - 08/2011
3	Amitriptyline (Elavil)FDA LinkGeneric 02/2015 - 01/2013
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 02/2015 - 01/2013
3	Interleukin-6 (Interleukin 6)IBA 11/2014 - 05/2008
3	propentofyllineIBA 09/2013 - 06/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 06/2004
3	fluorocitrateIBA 09/2013 - 05/2008
3	Interleukin-10 (Interleukin 10)IBA 09/2013 - 05/2008
2	N- (1- (3- (3,5- difluorophenyl)- 3- (4- methanesulfonylphenyl)propyl)piperidin- 4- yl)- N- ethyl- 2- (4- methanesulfonylphenyl)acetamideIBA 07/2023 - 03/2023
2	SB328437IBA 07/2023 - 01/2021
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2023 - 01/2019
2	Oxycodone (Oxycontin)FDA LinkGeneric 05/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 05/2023 - 09/2013
2	CCR4 ReceptorsIBA 12/2022 - 01/2020
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2021 - 01/2013
2	Lidocaine (Xylocaine)FDA LinkGeneric 03/2021 - 10/2016
2	Capsaicin (Zostrix)FDA Link 03/2021 - 11/2006
2	Peptides (Polypeptides)IBA 01/2021 - 01/2016
2	CCR ReceptorsIBA 01/2021 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 10/2020 - 11/2017
2	cenicrivirocIBA 07/2020 - 01/2020
2	EnkephalinsIBA 04/2020 - 01/2017
2	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2020 - 01/2014
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2020 - 01/2018
2	zaprinastIBA 02/2019 - 11/2018
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2018 - 06/2004
2	preproenkephalinIBA 10/2018 - 11/2014
2	EnzymesIBA 01/2018 - 03/2016
2	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2018 - 03/2016
2	tricarbonyldichlororuthenium (II) dimerIBA 01/2017 - 02/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2016 - 01/2013
2	Immunoglobulin G (IgG)IBA 06/2016 - 01/2015
2	NF-kappa B (NF-kB)IBA 01/2016 - 09/2013
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2015 - 09/2008
2	Milnacipran (Ixel)FDA Link 02/2015 - 01/2013
2	Fluoxetine (Prozac)FDA LinkGeneric 02/2015 - 01/2013
2	endomorphin 1IBA 12/2013 - 05/2004
2	Glutamic Acid (Glutamate)FDA Link 02/2013 - 12/2009
2	Glutamate Receptors (Glutamate Receptor)IBA 02/2013 - 09/2008
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 02/2013 - 09/2008
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 01/2013
2	TRPV Cation ChannelsIBA 01/2007 - 11/2006
1	SB 225002IBA 07/2023
1	vMIP-IIIBA 07/2023
1	plerixafor FDA Link 07/2023
1	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 07/2023

Therapy/Procedure

32	Analgesia 07/2023 - 05/2008
21	Therapeutics 07/2023 - 01/2009
11	Drug Therapy (Chemotherapy) 11/2023 - 10/2016
9	Spinal Injections 12/2022 - 11/2006
3	Intraperitoneal Injections 10/2020 - 11/2009
3	Ligation 11/2018 - 01/2007
2	Injections 03/2021 - 01/2016
2	Pain Management 03/2021 - 01/2018